NCT01920113View on ClinicalTrials.gov

A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Early Gastric Cancer Patients Who Were Scheduled for Endoscopic Submucosal Dissection
Interventions
DRUG

Dexmedetomidine - remifentanil group

DRUG

Propofol - remifentanil group

Trial Locations (1)

120-752

Anesthesiology & Pain Medicine, Yonsei university college of medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01920113 - A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil | Biotech Hunter | Biotech Hunter